Immunotherapy Doublet Shows Promise for Nonsurgical Control of Small Kidney Cancers
(MedPage Today) -- AUSTIN, Texas -- Unresectable nonmetastatic kidney cancers regressed substantially, but not completely, in response to treatment with nivolumab (Opdivo) and ipilimumab (Yervoy), a small prospective study showed.
Six of eight...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news
More News: Cancer | Cancer & Oncology | Hematology | Immunotherapy | Study | Urology & Nephrology | Yervoy